A systematic review of interventions for diabetic retinopathy, published in the American Journal of Ophthalmology, has found that intensive insulin pump therapy, compared to multiple… Read More »Systematic review and meta-analyses indicates that intensive insulin therapy reduces incidence of diabetic retinopathy
by Dr. Gearóid Tuohy Dear EURETINA Members, A very warm welcome to the November 16th, 2015 edition of EURETINA’s web-based digital magazine, “EURETINA… Read More »November 17th, 2015: “EURETINA-Brief”© Issue No. 121
Research from Tufts University, Boston, has indicated that evidence remains inconclusive in regards to whether or not zinc intake from foods and supplements is beneficial… Read More »The effects of zinc on the prevention and treatment of AMD are far from conclusive, according to a systematic review
The London Project to Cure Blindness, launched by Professor Pete Coffey, Professor of Cellular Therapies at the Institute of Ophthalmology, University College London, has announced… Read More »The London Project, supported by Pfizer Inc. initiate UK phase I stem cell trial for treatment of AMD
Research conducted at the Cantonal Hospital of Lucerne, Switzerland suggests that treatment of newly diagnosed AMD patients with either aflibercept or ranibizumab appear to provide… Read More »Analysis of clinical practice in treatment of newly diagnosed wet AMD patients suggests similar outcomes between aflibercept and ranibizumab.
A comprehensive 5-year prospective study across 72 centres in the US has shown that a significant level of antibiotic resistance exists among common ocular pathogens.… Read More »Nationwide study in the US indicates antibiotic resistance among ocular pathogens remains high.
by Dr. Gearóid Tuohy Dear EURETINA Members, A very warm welcome to the November 3rd, 2015 edition of EURETINA’s web-based digital magazine,… Read More »November 3rd, 2015: “EURETINA-Brief”© Issue No. 120
Research from Tufts University, Boston, has indicated that evidence remains inconclusive in regards to whether or not zinc intake from foods and supplements is beneficial… Read More »The effects of zinc on the prevention and treatment of AMD are far from conclusive, according to a systematic review
Ocata Therapeutics Inc. (NASDAQ:OCAT), based in Marlborough, Massachusetts, and formerly known as Advanced Cell Technology Inc., or ACT, have announced the enrollment of their first… Read More »Ocata Therapeutics Inc., announces enrolment of first patient in embryonic stem cell derived therapy treatment for dry age-related macular degeneration
Spark Therapeutics (NASDAQ:ONCE), a gene therapy company based in Philadelphia, USA, has announced the results of what the company claims to be the “first randomized,… Read More »Phase III data is announced from a randomised controlled cross-over gene therapy trial for LCA treatment